Atlas Trials

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

Clinical trial NCT02823366 · UNKNOWN

Trial details

NCT number
NCT02823366
Sponsor
Xijing Hospital of Digestive Diseases
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Biliary Cirrhosis
Start date
2016-01-01
Primary completion
2023-12-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.